Home/Filings/4/0001127602-21-024072
4//SEC Filing

FergusonMchugh MaryLynn 4

Accession 0001127602-21-024072

CIK 0000080424other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 8:24 PM ET

Size

12.0 KB

Accession

0001127602-21-024072

Insider Transaction Report

Form 4
Period: 2021-08-17
FergusonMchugh MaryLynn
Group President - Europe
Transactions
  • Award

    Common Stock

    2021-08-17+28,680149,535.927 total
  • Sale

    Common Stock

    2021-08-17$144.37/sh12,934$1,867,295136,601.927 total
  • Award

    Restricted Stock Units

    2021-08-16+112.5542,325.496 total
    Common Stock (112.554 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    28,355.953
  • Common Stock

    (indirect: By Trust)
    25,160.964
  • Common Stock

    (indirect: By Spouse)
    134.993
  • Common Stock

    (indirect: By Trust)
    0
Footnotes (6)
  • [F1]Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan.
  • [F2]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
  • [F3]Shares sold to cover taxes on Stock Award.
  • [F4]Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request.
  • [F5]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
  • [F6]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Issuer

PROCTER & GAMBLE Co

CIK 0000080424

Entity typeother

Related Parties

1
  • filerCIK 0001613133

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 8:24 PM ET
Size
12.0 KB